Evidence map›Paper›PMID 18216116›Full record

ArticleJournal of virology2008

Single-cell, phosphoepitope-specific analysis demonstrates cell type- and pathway-specific dysregulation of Jak/STAT and MAPK signaling associated with in vivo human immunodeficiency virus type 1 infection.

Andrew W Lee, Elizabeth R Sharp, Alison O'Mahony, Michael G Rosenberg, Dennis M Israelski, Garry P Nolan, Douglas F Nixon

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. The STAT Signaling Pathway in HIV-1 Infection: Roles and Dysregulation.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Imaging flow cytometry: coping with heterogeneity in biological systems.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2012
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Andrew W LeeDivision of Experimental Medicine, University of California at San Francisco, 1001 Potrero Ave., Bldg. 3, UCSF Box 1234, San Francisco, CA 94143-1234, USA.
Elizabeth R Sharp
Alison O'Mahony
Michael G Rosenberg
Dennis M Israelski
Garry P Nolan
Douglas F Nixon
Baxter (United States) · USUniversity of California, San Francisco · USGladstone Institutes · USJacobi Medical Center · USStanford University · US

Funding

Cell Mediated Immunity in HIV Infected ChildrenR01AI060379 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NIXON, DOUGLAS F · 2005 to 2009
$1.6M
Cell Mediated Immunity in HIV Infected ChildrenR21AI060379 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI NIXON, DOUGLAS F · 2004 to 2004
$374k
Aberrant Cell Signaling and HIV-Related Immune ActivationK08AI067064 · NIAID · STANFORD UNIVERSITY · PI LEE, ANDREW WEN-TSENG · 2005 to 2007
$220k
NIAID NIH HHS AI060379NIAID NIH HHS K08 AI067064NIAID NIH HHS R01 AI060379NIAID NIH HHS R21 AI060379
6 · The paper itself

Abstract

Despite extensive evidence of cell signaling alterations induced by human immunodeficiency virus type 1 (HIV-1) in vitro, the relevance of these changes to the clinical and/or immunologic status of HIV-1-infected individuals is often unclear. As such, mapping the details of cell type-specific degradation of immune function as a consequence of changes to signaling network responses has not been readily accessible. We used a flow cytometric-based assay of signaling to determine Janus kinase/signal transducers and activators of transcription (Jak/STAT) signaling changes at the single-cell level within distinct cell subsets from the primary immune cells of HIV-1-infected donors. We identified a specific defect in granulocyte-macrophage colony-stimulating factor (GM-CSF)-driven Stat5 phosphorylation in the monocytes of HIV-1+ donors. This inhibition was statistically significant in a cohort of treated and untreated individuals. Ex vivo Stat5 phosphorylation levels varied among HIV-1+ donors but did not correlate with CD4(+) T-cell counts or HIV-1 plasma viral load. Low Stat5 activation occurred in HIV-1-infected donors despite normal GM-CSF receptor levels. Investigation of mitogen-activated protein kinase (MAPK) pathways, also stimulated by GM-CSF, led to the observation that lipopolysaccharide-stimulated extracellular signal-regulated kinase phosphorylation is enhanced in monocytes. Thus, we have identified a specific, imbalanced monocyte signaling profile, with inhibition of STAT and enhancement of MAPK signaling, associated with HIV-1 infection. This understanding of altered monocyte signaling responses that contribute to defective antigen presentation during HIV-1 infection could lead to immunotherapeutic approaches that compensate for the deficiency.

Indexed as

Extracellular Signal-Regulated MAP KinasesSignal TransductionAdolescentAntigens, SurfaceCD4 Lymphocyte CountCells, CulturedChildChild, PreschoolFemaleFlow CytometryHIV-1HIV InfectionsHumansInfantMaleMonocytesAntigens, SurfaceExtracellular Signal-Regulated MAP KinasesReceptors, Granulocyte-Macrophage Colony-Stimulating FactorSTAT5 Transcription Factor

Identifiers

PMID18216116
PMCPMC2268489
OpenAlexW2097785168

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.